Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 2 February 2026

Robinhood stock tumbles as Bitcoin whipsaws; HOOD earnings set the next test

Robinhood stock tumbles as Bitcoin whipsaws; HOOD earnings set the next test

Robinhood shares fell 7.7% to $91.87 by midday Monday, tracking declines in crypto-linked stocks as Bitcoin rebounded to $78,939. Piper Sandler maintained its $155 target but warned of weaker crypto volumes and seasonal headwinds. Traders await Robinhood’s Feb. 10 earnings for insight into retail activity. The company’s expansion into prediction markets adds a new variable for investors.
2 February 2026
·····
CoreWeave stock slips as class-action notices pile up ahead of earnings

CoreWeave stock slips as class-action notices pile up ahead of earnings

CoreWeave shares fell 1.5% to $91.82 by midday Monday after new class action lawsuits alleged false statements and highlighted disclosure risks. Investors are awaiting the Feb. 18 earnings report for updates on capacity and spending. The stock faces pressure from litigation headlines and concerns over funding and delivery timelines. Nvidia and Microsoft also slipped, while Alphabet rose.
2 February 2026
····
IREN Limited stock slides as bitcoin miners wobble ahead of earnings this week

IREN Limited stock slides as bitcoin miners wobble ahead of earnings this week

IREN Limited shares fell 3.7% to $51.74 by midday Monday on Nasdaq, with trading volume reaching 20.1 million. The drop followed sharp swings in bitcoin, which climbed 1.7% to $78,864 after a weekend slump. Other U.S.-listed miners also declined. IREN will report quarterly results Thursday, with investors watching for updates on AI cloud growth and mining margins.
2 February 2026
·······
Lumentum stock (Nasdaq: LITE) jumps 13% as earnings day nears

Lumentum stock (Nasdaq: LITE) jumps 13% as earnings day nears

Lumentum shares jumped 13.1% to $443.13 by midday Monday after hitting $448.24, ahead of fiscal Q2 earnings due Tuesday after the close. The company forecast Q2 revenue of $630 million to $670 million and a non-GAAP operating margin of 20% to 22%. Morgan Stanley raised its price target to $350 but kept an equal-weight rating. Trading volume reached about half the three-month average.
2 February 2026
··
Eli Lilly stock price climbs as obesity-drug forecasts get a reality check before earnings

Eli Lilly stock price climbs as obesity-drug forecasts get a reality check before earnings

Eli Lilly shares rose 1.5% to close near $1,052.70 Monday, recovering from early losses ahead of its earnings report due Wednesday. Analysts have cut long-term forecasts for obesity drugs as prices fall and competition intensifies, with 2030 sales estimates for GLP-1 drugs dropping to about $100 billion. Investors are focused on Lilly’s pricing strategy and demand outlook. The FDA is set to rule on Lilly’s weight-loss pill by April 10.
2 February 2026
····
Lumentum stock jumps 12% ahead of earnings — what traders are watching next

Lumentum stock jumps 12% ahead of earnings — what traders are watching next

Lumentum shares surged 12.2% to $439.52 in late morning trading Monday, ahead of its fiscal Q2 earnings report due after Tuesday’s close. About 2.6 million shares traded as investors focused on demand from AI data centers and margin outlook. Peers Coherent and Ciena also rose over 6%. Lumentum previously forecast Q2 revenue of $630–$670 million and adjusted EPS of $1.30–$1.50.
2 February 2026
··
Opendoor stock slips in early trade as mortgage-rate outlook stays cloudy ahead of Feb. 19 results

Opendoor stock slips in early trade as mortgage-rate outlook stays cloudy ahead of Feb. 19 results

Opendoor shares fell 1.6% to $5.07 in early Monday trading, with volume at 11.7 million shares. The dip followed a slight drop in mortgage rates after the Fed paused on interest rates. Investors are watching for Opendoor’s Feb. 19 earnings and “Financial Open House” event. The company reported $1.9 billion in non-recourse asset-backed loans as of December 31.
2 February 2026
···
Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next

Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next

Twist Bioscience shares surged 14% to $46.88 Monday after posting record Q1 revenue of $103.7 million and raising its full-year forecast. Gross margin reached 52%, with net loss narrowing to $30.5 million. The company reaffirmed its target to reach adjusted EBITDA breakeven by late fiscal 2026. Investors are watching if Twist can sustain margins and meet its March-quarter revenue guidance.
2 February 2026
···
Broadcom stock price: AVGO sets March earnings date as VMware partner shake-up grabs attention

Broadcom stock price: AVGO sets March earnings date as VMware partner shake-up grabs attention

Broadcom shares edged up 0.1% to $331.54 in early trading Monday as the company set its Q1 earnings call for March 4. Reports surfaced that VMware, acquired by Broadcom in 2023, will not renew contracts with some cloud partners, raising concerns over its software strategy. Investors are watching for updates on AI chip demand and potential margin pressure. Chip stocks traded mixed, with Nvidia down and AMD up.
2 February 2026
···
Palantir stock rises ahead of earnings after William Blair upgrade puts $200 back in play

Palantir stock rises ahead of earnings after William Blair upgrade puts $200 back in play

Palantir shares climbed 2.2% to $149.82 Monday morning ahead of quarterly results due after the close. William Blair upgraded the stock, projecting a return above $200 within 12 months and citing strong December quarter signals. The stock remains down about 30% from its record high. Investors await management’s outlook on commercial demand and margins amid volatile AI sector trading.
2 February 2026
··
Amazon stock ticks up as analyst lifts target ahead of Feb. 5 earnings test

Amazon stock ticks up as analyst lifts target ahead of Feb. 5 earnings test

Amazon shares rose 0.5% to $240.51 Monday after Citizens JMP raised its price target to $315 ahead of Thursday’s earnings. Analyst Andrew Boone cited AWS growth and AI investments, but warned of possible cloud capacity limits. U.S. stocks opened lower, with the S&P 500 down 0.2% and Nasdaq off 0.4%. Investors are focused on Amazon’s cloud margins and AI spending.
2 February 2026
···
Nvidia stock slips early as OpenAI deal doubts hang over NVDA ahead of Feb. 25 results

Nvidia stock slips early as OpenAI deal doubts hang over NVDA ahead of Feb. 25 results

Nvidia shares fell 0.7% to $191.13 in early Monday trading after reports of internal pushback on its planned OpenAI investment of up to $100 billion. Both companies are reconsidering the partnership, with Nvidia’s CEO calling the $100 billion figure non-binding. Investors are watching Nvidia’s quarterly earnings, set for Feb. 25, as market nerves persist after a commodities sell-off.
2 February 2026
·····
SoFi stock whipsaws after $1B quarter — what could move SOFI next this week

SoFi stock whipsaws after $1B quarter — what could move SOFI next this week

SoFi shares dropped 6.4% Friday to $22.81 after posting its first $1 billion revenue quarter and raising 2026 targets. The company reported Q4 net revenue of $1.025 billion and projected 2026 adjusted net revenue of $4.655 billion. Investors are watching credit trends and U.S. rate data this week amid concerns over lending risk and technology platform growth.
2 February 2026
··
NIO stock slips in premarket as January deliveries jump 96%, but the next test is close

NIO stock slips in premarket as January deliveries jump 96%, but the next test is close

NIO shares slipped 1.3% to $4.70 in Monday premarket trading, despite January deliveries nearly doubling from a year earlier to 27,182 vehicles. The figure fell 44% from December’s record. Broader Chinese EV sales dropped sharply in January after tax incentives expired. Investors remain cautious as sector discounts and rising costs weigh on sentiment.
2 February 2026
······
1 … 20 21 22 23 24 … 202

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop